Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03474380 · ClinicalTrials.gov registry record · NA
Optimizing Function and Independence Through iHI-FIVES
A NA study of Cognitive Impairment and Functional Impairment, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,406
- Enrollment target
- 1
- Study location
NCT03474380: Completed NA study of Cognitive Impairment and Functional Impairment, sponsored by VA Office of Research and Development.
NCT03474380 is a NA study of Cognitive Impairment and Functional Impairment that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,406 participants, above the 652-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (116% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03474380, a NA study of Cognitive Impairment and Functional Impairment, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,406 participants
- Enrollment target
- 1
- Study location
Study Summary
Optimizing Function and Independence Through iHI-FIVES aims to implement the iHI-FIVES caregiver skills training program at 8 VAMC sites in a stepped- wedge design and evaluate caregiver and patient outcomes before and after the program is implemented, as well as the efficacy of a usual vs enhanced implementation design.
Primary Outcome
Count of number of days not at home (e.g. days in emergency department, inpatient hospital, or post-acute facility setting) over 180 days following study determination of eligibility (e.g. referred to home based care and has a caregiver). The outcome will be assessed via administrative data (not patient report). Outcome was at the participant level according to the usual care and intervention as pre-specified in the study protocol. Participants were either in usual care or intervention (offering
Conditions Studied
Interventions
- BEHAVIORAL iHI-FIVES
Study Locations (1)
North Carolina
- Durham VA Medical Center, Durham, NC - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,406 participants |
| Start Date | 2018-04-23 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
What the finished NCT03474380 record still lists
NCT03474380 is an interventional study that assigns participants to a tested intervention. Its 1,406 participants enrollment target places it among the larger protocols in the corpus, above the 652-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (116% higher).
The record links to 2 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which iHI-FIVES is the first listed.
NCT03474380 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03474380 about?
NCT03474380 is a clinical study titled "Optimizing Function and Independence Through iHI-FIVES". Optimizing Function and Independence Through iHI-FIVES aims to implement the iHI-FIVES caregiver skills training program at 8 VAMC sites in a stepped- wedge design and evaluate caregiver and patient outcomes before and after the program is implemented, as well as the efficacy of a usual vs enhanced ...
What is the current status of trial NCT03474380?
This trial is currently completed. It is a NA study. The enrollment target is 1,406 participants. The study started on 2018-04-23. Estimated completion is 2021-10-31.
What conditions does trial NCT03474380 study?
This clinical trial studies the following conditions: Cognitive Impairment, Functional Impairment.
What interventions are being tested in trial NCT03474380?
The interventions under investigation include: iHI-FIVES (BEHAVIORAL).
Who is sponsoring clinical trial NCT03474380?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03474380 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03474380's enrollment target sits among peer trials
1,406 5th of 105 higher than 101 of 105 other Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05992935 · 1,405 participants · Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
- NCT05444582 · 1,404 participants · Phase 4
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
- NCT05890404 · 1,410 participants · NA
SGM Evidenced-Based Mental Healthcare Implementation
- NCT07042451 · 1,410 participants · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI